Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Analysis of Mutational Landscape in Systemic Anaplastic Large Cell Lymphoma Identifies Novel Prognostic Markers

Blood (2019) 134 (Supplement_1): 1490.

https://doi.org/10.1182/blood-2019-126501

Published: 2019

Journal Articles

Inhibition of DOT1L and PRMT5 Promotes Anti-Tumor Activity in a Human MLL Leukemia Model Induced By CRISPR/Cas9

Kathy-Ann Secker, MSc, Hildegard Keppeler, Silke Duerr-Stoerzer, Hannes Schmid, MSc, Dominik Schneidawind, MD, Thomas Hentrich, PhD, Julia Schulze-Hentrich, PhD, Barbara Mankel, Falko Fend, MD, Lothar Kanz, Corina Schneidawind, MD

Blood (2018) 132 (Supplement 1): 5147.

https://doi.org/10.1182/blood-2018-99-115975

Published: 2018

Journal Articles

Identification and Characterization of HLA Class I-Restricted MYD88 L265P-Derived Peptides As Tumor-Specific Targets for Immunotherapy

Annika Nelde, Juliane S Stickel, MD, Daniel Johannes Kowalewski, Oliver Olaf Wolz, Lothar Kanz, MD, Anton W. Langerak, Alice F. Muggen, Irina Bonzheim, Falko Fend, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Alexander N.R. Weber

Blood (2015) 126 (23): 2750.

https://doi.org/10.1182/blood.V126.23.2750.2750

Published: 2015

Journal Articles

Constitutive gp130-JAK-STAT3 Signaling Induces a Plasma Cell Disorder Representing Genetic and Clinical Features of Human Myeloma – a Novel in Vivo Model for the Patient Subgroup Characterized By a STAT3 Target Gene Signature

Sabine Steidle, MD, Tobias Dechow, MD, Katharina Götze, Martina Rudelius, MD, Konstanze Pechloff, PhD, Kerstin Behnke, Lars Bullinger, MD PhD, Falko Fend, MD, Soberon Valeria, PhDstudent, Marc Schmidt-Supprian, PhD, Florian Bassermann, MD, Jürgen Ruland, MD, Christian Peschel, MD, Ulrich Keller, MD

Blood (2014) 124 (21): 648.

https://doi.org/10.1182/blood.V124.21.648.648

Published: 2014

Journal Articles

Involvement Of S100 Proteins and Hsp90 In The Pathogenesis Of Graft-Versus-Host Disease After Allogeneic Hematopoetic Cell Transplantation

Katharina Reinhardt, Dirk Föll, MD, Thomas Vogl, PhD, Falko Fend, MD, Christian Gille, MD, Tobias Feuchtinger, MD, Peter Lang, MD, Rupert Handgretinger, Wolfgang A. Bethge, MD, Ursula Holzer, MD

Blood (2013) 122 (21): 2058.

https://doi.org/10.1182/blood.V122.21.2058.2058

Published: 2013

Journal Articles

Targeting CDK4 in Mantle Cell Lymphoma (MCL) Cell Lines by Specific Lentiviral shRNA Mediated Knockdown Has Profound Effects on Cell Growth and Cell Cycle but Minimal Effects on Apoptosis.

Margit Klier, Irina Bonzheim, PhD, Natasa Anastasov, PhD, Daniela Angermeier, Mark Raffeld, MD, Falko Fend, MD, Leticia Quintanilla-Martinez, MD

Blood (2008) 112 (11): 1767.

https://doi.org/10.1182/blood.V112.11.1767.1767

Published: 2008

Journal Articles

C/EBPβ Expression in ALK+ Anaplastic Large Cell Lymphomas (ALCL) Is Regulated by Stat3 Signaling Pathway.

Natasa Anastasov, PhD, Martina Rudelius, MD, Margit Klier, Therese Dau, Daniela Angermeier, Stefania Pittaluga, PhD, MD, Justus Duyster, MD, Falko Fend, MD, Mark Raffeld, MD, Leticia Quintanilla-Martinez, PD., MD

Blood (2007) 110 (11): 3570.

https://doi.org/10.1182/blood.V110.11.3570.3570

Published: 2007

Journal Articles

Functional Analysis of Cyclin D1 in Mantle Cell Lymphoma (MCL) by Specific Lentiviral shRNA Mediated Knockdown.

Margit Klier, Natasa Anastasov, PhD, Daniela Angermeier, Mark Raffeld, MD, Falko Fend, MD, Leticia Quintanilla-Martinez, MD

Blood (2007) 110 (11): 1584.

https://doi.org/10.1182/blood.V110.11.1584.1584

Published: 2007

Journal Articles

The BCR-Associated Tyrosine Kinase SYK Is Linked to the Activation of AKT in Mantle Cell Lymphoma.

Martina Rudelius, MD, Denise Sebasigari, BA, Yoko Tabe, MD, Theresa Davies-Hill, BA, Falko Fend, MD, Quintanilla-Martinez Leticia, MD, Jaffe S. Elaine, MD, Pittaluga Stefania, MD, PhD, Raffeld Mark, MD

Blood (2007) 110 (11): 1586.

https://doi.org/10.1182/blood.V110.11.1586.1586

Published: 2007

Journal Articles

Constitutive Activation of AKT Contributes to the Pathogenesis and Survival of Blastoid Variants of Mantle Cell Lymphoma.

Martina Rudelius, MD, Stefania Pittaluga, MD, Trinh H.-T. Pham, Thomas Fountaine, III, Leticia Quintanilla-Martinez, MD, Falko Fend, MD, Elaine S. Jaffe, MD, Mark Raffeld, MD

Blood (2005) 106 (11): 1908.

https://doi.org/10.1182/blood.V106.11.1908.1908

Published: 2005

NARROW

Analysis of Mutational Landscape in Systemic Anaplastic Large Cell Lymphoma Identifies Novel Prognostic Markers

Inhibition of DOT1L and PRMT5 Promotes Anti-Tumor Activity in a Human MLL Leukemia Model Induced By CRISPR/Cas9

Identification and Characterization of HLA Class I-Restricted MYD88 L265P-Derived Peptides As Tumor-Specific Targets for Immunotherapy

Constitutive gp130-JAK-STAT3 Signaling Induces a Plasma Cell Disorder Representing Genetic and Clinical Features of Human Myeloma – a Novel in Vivo Model for the Patient Subgroup Characterized By a STAT3 Target Gene Signature

Involvement Of S100 Proteins and Hsp90 In The Pathogenesis Of Graft-Versus-Host Disease After Allogeneic Hematopoetic Cell Transplantation

Targeting CDK4 in Mantle Cell Lymphoma (MCL) Cell Lines by Specific Lentiviral shRNA Mediated Knockdown Has Profound Effects on Cell Growth and Cell Cycle but Minimal Effects on Apoptosis.

C/EBPβ Expression in ALK+ Anaplastic Large Cell Lymphomas (ALCL) Is Regulated by Stat3 Signaling Pathway.

Functional Analysis of Cyclin D1 in Mantle Cell Lymphoma (MCL) by Specific Lentiviral shRNA Mediated Knockdown.

The BCR-Associated Tyrosine Kinase SYK Is Linked to the Activation of AKT in Mantle Cell Lymphoma.

Constitutive Activation of AKT Contributes to the Pathogenesis and Survival of Blastoid Variants of Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only